You’ll Want To Read This If You Own SNY, TWC, or TRI

Recent earnings results from Sony (SNY), Time Warner Cable (TWC) and Thomson (TRI) led me to revisit my Portfolio Grader Ratings, and they are worth a look More 

It May Be Time to Trim Away at Your Portfolio

The stock market is doing well for October, but its may be time to look through your portfolio in order to trim away some of the upcoming losers More 

New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half

Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results. More 

Nasacort Allergy Spray Gets Over-the-Counter Approval

Sanofi, announced on Friday, that its Nasacort Allergy 24 Hour nasal spray had been approved as an over-the-counter drug. More 

Meet the New ‘Gold Standard’ for Flu Vaccines

This seemingly minor upgrade to 2013's key flu vaccines is not only a bigger deal than most presume, but what's in the works could be even bigger. More 

46 Actions To Take Now That The Dollar Has Cracked

The U.S. dollar has cracked, with the currency falling to a seven-month low against the euro and Yen. Here's what you should do now in your portfolio More 

FDA Reviewers: Nasacort Allergy Spray Can Go OTC

Sanofi's Nasacort anti-asthma treatment has been declare safe enough for non-prescription sales by U.S. Food and Drug Administration reviewers. More